US Broker Ratings

BrightSpring Health Services (BTSG) Stock Analysis: Navigating a 25.60% Revenue Growth in Healthcare Services

BrightSpring Health Services, Inc. (BTSG), headquartered in Louisville, Kentucky, has emerged as a formidable player in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization..

Grifols, S.A. (GRFS) Stock Analysis: Evaluating the 46.82% Potential Upside for Investors

Grifols, S.A. (GRFS), a prominent figure in the healthcare sector, is a global player renowned for its expertise in the research, development, production, and marketing of plasma-derived medicines. With its..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 29.98% Potential Upside Amid Healthcare Growth

Option Care Health, Inc. (NASDAQ: OPCH), a key player in the U.S. healthcare sector, stands out in the medical care facilities industry with its specialized infusion services. With a market..

Solventum Corporation (SOLV) Stock Report: Insights into a Healthcare Giant with 8.91% Potential Upside

Solventum Corporation (SOLV) has piqued the interest of investors with its comprehensive range of healthcare solutions and a promising potential upside of 8.91%. This healthcare powerhouse, headquartered in Eagan, Minnesota,..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Insights on Performance and Growth Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector with a focus on medical devices, has been a key player in orthopedic solutions since its founding in..

Integer Holdings Corporation (ITGR) Stock Analysis: A Closer Look at Its 7.25% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, has been catching the eye of investors recently. With a current stock price of..

Avantor, Inc. (AVTR) Stock Analysis: A Healthcare Giant with Limited Upside and Mixed Ratings

Avantor, Inc. (AVTR) is a prominent player in the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Radnor, Pennsylvania, Avantor offers a wide range of mission-critical..

Tempus AI, Inc. (TEM) Stock Analysis: Unpacking the 30.87% Upside Potential for Investors

Tempus AI, Inc. (TEM) has emerged as a noteworthy player in the healthcare technology industry, leveraging cutting-edge solutions to transform health information services. With a market capitalization of $9.13 billion,..

Alkermes plc (ALKS) Stock Analysis: Navigating Growth in Biopharmaceuticals with a 4.88% Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is making waves with a market capitalization of $7.5 billion. Headquartered in Dublin, Ireland, this biopharmaceutical company is at..

Atrium Therapeutics, Inc. (RNA): Analyst Ratings Signal 97% Upside Potential in Promising Biotechnology Sector

Atrium Therapeutics, Inc. (NASDAQ: RNA) stands at the forefront of the biotechnology industry with its innovative focus on RNA therapeutics targeting cardiomyopathies. Headquartered in San Diego, California, Atrium Therapeutics is..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 16% Upside Potential

Investors with a keen eye on the biotechnology sector may find argenx SE (NASDAQ: ARGX) an enticing prospect. Headquartered in Amsterdam, the Netherlands, argenx is a commercial-stage biopharmaceutical company squarely..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 41.54% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, has caught the eye of investors with its significant upside potential. Despite a challenging financial landscape, the company’s..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Ups and Downs in a Dynamic Healthcare Market

Oscar Health, Inc. (OSCR) presents an intriguing opportunity for investors interested in the dynamic healthcare sector. As a healthcare technology company, Oscar Health is at the forefront of offering innovative..

Centene Corporation (CNC) Stock Analysis: Navigating Growth in the Healthcare Sector with a Market Cap of $30.13 Billion

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, continues to capture investor attention with its robust market capitalization of $30.13 billion. Headquartered in Saint Louis, Missouri,..

McKesson Corporation (MCK) Stock Analysis: A Potential 25% Upside Amid Robust Revenue Growth and Strong Buy Ratings

As one of the largest and most diversified healthcare services companies in the world, McKesson Corporation (NYSE: MCK) holds a commanding position in the medical distribution industry. With a market..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A $10.26 Billion Market Cap Player in Gene Therapy with Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS) has been making waves in the biotechnology sector, drawing attention from investors with its innovative approach to genetic medicine. With a current market capitalization of..

The Ensign Group (ENSG) Stock Analysis: Unveiling a 43% Upside Potential in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG) has been garnering attention in the medical care facilities industry for its robust growth and promising future prospects. Operating across multiple states in the..

Investor Outlook: Jazz Pharmaceuticals plc (JAZZ) and Its 14.40% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology industry, continues to draw attention from investors with its robust pipeline and significant market presence. Based in Dublin, Ireland,..

Elanco Animal Health (ELAN) Stock Analysis: 23% Potential Upside Beckons Investors

Elanco Animal Health Incorporated (NYSE: ELAN), a significant player in the healthcare sector focused on animal health, presents a compelling opportunity for investors seeking exposure in the drug manufacturing industry...

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Potential 44% Upside Amid Promising Pipeline and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing the attention of investors with its robust growth potential and significant upside opportunity. With a market capitalization of $6.64 billion, this Boston-based biopharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds